The largest database of trusted experimental protocols

Protease 2

Manufactured by Roche
Sourced in United States

Protease 2 is a laboratory instrument designed to facilitate the study and analysis of proteins. It is a versatile tool used for the detection, separation, and characterization of various protease enzymes. The core function of Protease 2 is to enable researchers to isolate and identify specific proteases, which play a crucial role in various biological processes.

Automatically generated - may contain errors

7 protocols using protease 2

1

Prion Decontamination and Immunohistochemical Analysis of Formalin-Fixed Brain Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Formalin fixed brain hemispheres were decontaminated in formic acid for 60 min to eliminate prion infectivity. After additional fixation in formalin, the tissue was paraffin embedded. Paraffin sections (3 μm) were stained with H&E. Immunohistochemical stainings for GFAP (1:13000 DAKO) and IBA1 (1:1000) were performed using standard methods. For SAF84 immunostains, sections were incubated in 98% formic acid for an additional 6 min after deparaffinization and washed in distilled water for 30 min. Sections were treated with citrate buffer (pH 6.0) for 3 min at 100°C. After adapting to room temperature, sections were incubated in Ventana buffer, and stained with the NEXEX immunohistochemistry robot (Ventana Instruments) using an iVIEW DAB Detection Kit (Ventana). After incubation with protease 2 (Ventana) for 16 min, sections were incubated with anti-PrP SAF-84 (SPI-Bio, A03208, 1:200) for 32 min and counterstained with hematoxylin.
+ Open protocol
+ Expand
2

Immunostaining of EGFRvIII-expressing GBM Xenograft

Check if the same lab product or an alternative is used in the 5 most similar protocols
An EGFRvIII-expressing human GBM (GBM39) was propagated as a xenograft40 (link) and kindly provided by C. David James (Department of Neurological Surgery, University of California San Francisco). Harvested tumor tissue was formalin-fixed, paraffin-embedded, and cut into 4 µm sections for mounting on positively-charged slides. Antigen retrieval was performed using protease 2 (Ventana). Sections were immunostained with primary antibodies targeting phospho-Tyr-845 (1:150; Abcam) and human uPAR (1:75; Dako) for 1 h at 37°C using the Ventana Discovery Ultra Platform. Q-dot-linked fluorescent secondary antibodies (1:150; Invitrogen) were added for 1 h. The slides were rinsed and cover-slipped with Prolong Gold and DAPI (Invitrogen). Slides were visualized on a Zeiss Axio Imager2 using Cambridge Research Instruments Nuance Multispectral Imaging System software to capture images and visualize individual fluorophore spectra free from auto-fluorescence noise. In control experiments, phospho-epitope labeling was validated using protein phosphatase treatment, which eliminated signal.
+ Open protocol
+ Expand
3

Automated EBER-ISH for EBV Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
EBER-ISH was performed on the tissue sections using the BenchMark XT automated slide stainer (Ventana Medical Systems, Tucson, AZ, USA). The sections were treated with protease 2 (catalog no. 780-4147; Ventana Medical Systems) and labeled with an EBER probe (catalog no. 780-2842; Ventana Medical Systems) for 2 h. Hybridization products were visualized with Ventana ISH iView Blue Detection Kit (Ventana Medical Systems) according to the manufacturer’s instructions. Dark blue dots at the site of hybridization (nucleus) was regarded as positive for EBV.
+ Open protocol
+ Expand
4

Immunohistochemical Staining of CNS Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stainings were performed on 2 µm sections from formalin fixed, formic acid treated, paraffin embedded tissues. After deparaffinization through graded alcohols, heat-induced antigen retrieval was performed in EDTA-based buffer CC1 and stainings were performed on a NEXES immunohistochemistry robot (Ventana instruments) using the following antibodies: Iba1 (1:1000, Wako); GFAP (1:13000, Dako); SAF84 (1:200, SPI bio). Only for the latter staining, antibody incubation was preceded by incubation with protease 2 (Ventana). Immunoreactivity was visualized using an IVIEW DAB Detection Kit (Ventana). Haematoxylin and eosin staining was performed according to standard procedures. Slides were scanned with NanoZoomer and images were visualized using the NanoZoomer Digital Pathology System (NDPview, Hamamatsu Photonics).
+ Open protocol
+ Expand
5

Immunostaining of EGFRvIII-expressing GBM Xenograft

Check if the same lab product or an alternative is used in the 5 most similar protocols
An EGFRvIII-expressing human GBM (GBM39) was propagated as a xenograft40 (link) and kindly provided by C. David James (Department of Neurological Surgery, University of California San Francisco). Harvested tumor tissue was formalin-fixed, paraffin-embedded, and cut into 4 µm sections for mounting on positively-charged slides. Antigen retrieval was performed using protease 2 (Ventana). Sections were immunostained with primary antibodies targeting phospho-Tyr-845 (1:150; Abcam) and human uPAR (1:75; Dako) for 1 h at 37°C using the Ventana Discovery Ultra Platform. Q-dot-linked fluorescent secondary antibodies (1:150; Invitrogen) were added for 1 h. The slides were rinsed and cover-slipped with Prolong Gold and DAPI (Invitrogen). Slides were visualized on a Zeiss Axio Imager2 using Cambridge Research Instruments Nuance Multispectral Imaging System software to capture images and visualize individual fluorophore spectra free from auto-fluorescence noise. In control experiments, phospho-epitope labeling was validated using protein phosphatase treatment, which eliminated signal.
+ Open protocol
+ Expand
6

Quantitative Histological Analysis of Brain Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Histological analyses were performed on 2-μm thick sections from formalin fixed, formic acid treated, paraffin embedded brain tissues, as previously described[32 (link)]. Sections were subjected to deparaffinization through graded alcohols, followed by heat-induced antigen retrieval performed in EDTA-based buffer CC1 (Ventana). Stainings were performed on a NEXES immunohistochemistry robot (Ventana instruments) with the following antibodies: Iba1 (1:1000, Wako); GFAP (1:13000, Dako); SAF84 (1:200, SPI bio). For the latter staining, incubation with protease 2 (Ventana) was performed before antibody incubation. Immunoreactivity was visualized using an IVIEW DAB Detection Kit (Ventana). Haematoxylin and eosin stainings were performed according to standard procedures. Slides were scanned with NanoZoomer and images were acquired using the NanoZoomer Digital Pathology System (NDPview, Hamamatsu Photonics). High magnification pictures were quantified with an in-house developed python script by counting the number of HRP pixels, which were defined as pixels for which the following condition in RGB colour space holds true: R > G > B.
+ Open protocol
+ Expand
7

Immunohistochemistry Protocol for CD13 and Ki-67

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry was performed on 5 μm thick formalin-fixed paraffin embedded sections using the Discovery XT and Discovery Ultra research instruments (Ventana Medical Systems, Inc. Tucson, Arizona, USA). Sections were deparaffinized with Discovery EZ prep and then either heat retrieved with the proprietary solutions, Discovery RiboCC and Discovery CC1, or pretreated with Protease 2 (Ventana Medical Systems, Inc. Tucson, Arizona, USA) at 37˚C. Sections were then incubated with either CD13 or Ki-67 primary antibodies (abcam, Cambridge, Massachusetts, USA). The concentrations, temperature and incubation times were based on protocols optimized with positive control tissues. A systematic protocol for each antibody is listed in supplementary Tables 1 and 2.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!